652 related articles for article (PubMed ID: 4915546)
1. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
Velasco M; Losada M; Losada A; Ramirez G
Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
[No Abstract] [Full Text] [Related]
2. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
Miyawaki S; Ritchie RF
J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
[No Abstract] [Full Text] [Related]
3. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
Zitńan D; Cebecauer L
J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
[No Abstract] [Full Text] [Related]
4. The serology of connective tissue disorders.
Holborow EJ
Br J Hosp Med; 1978 Mar; 19(3):250, 252, 257-8. PubMed ID: 343858
[No Abstract] [Full Text] [Related]
5. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors].
Peltier AP; Strejcek G
Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485
[No Abstract] [Full Text] [Related]
6. [Detection of antinuclear factors in rheumatic diseases].
Ménard HA; Myhal D; Camerlain M; Lussier A
Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283
[No Abstract] [Full Text] [Related]
7. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
Parker MD; Kerby GP
Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
[No Abstract] [Full Text] [Related]
8. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
Diaz Gill GA; Beutner EH; Eisenberg RB
Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
[No Abstract] [Full Text] [Related]
9. Antinuclear antibodies in some internal diseases, especially autoimmunization diseases.
Lange A
Arch Immunol Ther Exp (Warsz); 1972; 20(2):209-26. PubMed ID: 4112512
[No Abstract] [Full Text] [Related]
10. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
Schmidt K; Mueller-Eckhardt C; Becker W
Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
[No Abstract] [Full Text] [Related]
11. [Allergy and collagen diseases].
Horiuchi Y; Hirose S
Naika; 1972; 29(1):83-9. PubMed ID: 4622138
[No Abstract] [Full Text] [Related]
12. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
13. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
[TBL] [Abstract][Full Text] [Related]
14. The immunofluorescent "band" test in mixed connective tissue disease.
Levitin PM; Weary PE; Giuliano VJ
Ann Intern Med; 1975 Jul; 83(1):53-5. PubMed ID: 1096702
[TBL] [Abstract][Full Text] [Related]
15. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
Dreher R; Helmke K
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
[No Abstract] [Full Text] [Related]
16. Antinucleolar antibodies. Their frequency and diagnostic association.
Ritchie RF
N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
[No Abstract] [Full Text] [Related]
17. Pathogenesis of connective tissue disease.
Holborow EJ
Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):712-20. PubMed ID: 4282889
[No Abstract] [Full Text] [Related]
18. [Immunofluorescent appearance of antinuclear antibodies and LE cells in connective tissue diseases].
Kolarzowska B
Pol Tyg Lek; 1970 Jan; 25(1):9-12. PubMed ID: 4189987
[No Abstract] [Full Text] [Related]
19. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
[No Abstract] [Full Text] [Related]
20. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
